DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.87% to $7.33 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.78% to 18,544.42 and Dow Jones Industrial Average falling 0.45% to 43,239.50.
This was the stock's fifth consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 88.16% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.21% to $4.70, Fortress Biotech Inc. (FBIO) fell 1.88% to $1.57, and Viking Therapeutics Inc. $(VKTX)$ rose 3.06% to $28.67.
Trading volume (120,097) remained 151,497 below its 50-day average volume of 271,594.
Data source: Dow Jones Market Data, FactSet. Data compiled February 27, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 27, 2025 17:25 ET (22:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。